rhmnjfr
2021-11-03
Nice try.
2 Meme Stocks With Short Squeeze Potential In November<blockquote>11月2只具有逼空潜力的Meme股票</blockquote>
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
3
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":848084998,"tweetId":"848084998","gmtCreate":1635948364567,"gmtModify":1635948371342,"author":{"id":3575552457926722,"idStr":"3575552457926722","authorId":3575552457926722,"authorIdStr":"3575552457926722","name":"rhmnjfr","avatar":"https://static.tigerbbs.com/c38827a746715f9db0eee24ada0d72b7","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":1,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Nice try.</p></body></html>","htmlText":"<html><head></head><body><p>Nice try.</p></body></html>","text":"Nice try.","highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/848084998","repostId":1194203181,"repostType":4,"repost":{"id":"1194203181","kind":"news","pubTimestamp":1635942663,"share":"https://www.laohu8.com/m/news/1194203181?lang=zh_CN&edition=full","pubTime":"2021-11-03 20:31","market":"us","language":"en","title":"2 Meme Stocks With Short Squeeze Potential In November<blockquote>11月2只具有逼空潜力的Meme股票</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1194203181","media":"TheStreet","summary":"Wall Street Memes lists two meme stocks that might be on the verge of a short squeeze. Will OCGN and","content":"<p>Wall Street Memes lists two meme stocks that might be on the verge of a short squeeze. Will OCGN and PROG head to the moon in November?</p><p><blockquote>华尔街模因列出了两只可能处于轧空边缘的模因股票。OCGN和PROG会在11月前往月球吗？</blockquote></p><p> “Meme frenzy” may seem to be hibernating, but it is certainly still alive under the sheets. Retail investors continue to monitor and debate several key stocks on the main discussion boards across the web, and some have started to move in the past few days – think GameStop on November 1, for example.</p><p><blockquote>“迷因狂潮”可能看起来正在冬眠，但它肯定仍然在床单下活着。散户投资者继续在网络上的主要讨论板上监控和辩论几只关键股票，其中一些股票在过去几天已经开始波动——例如，想想11月1日的游戏驿站。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/c8a435559be38d10b7251aa72e23a665\" tg-width=\"1240\" tg-height=\"698\" width=\"100%\" height=\"auto\"><span>Figure 1: Ocugen and Progenity logo.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图1：Ocugen和Progenity标志。</span></p></blockquote></p><p> Driven by popularity, momentum and elevated short interest, Wall Street Memes lists two meme stocks that have “mooning” potential in November.</p><p><blockquote>在受欢迎程度、势头和空头兴趣上升的推动下，华尔街模因列出了两只在11月份具有“月亮”潜力的模因股票。</blockquote></p><p> <b>1. Ocugen, Inc.</b></p><p><blockquote><b>1.Ocugen公司。</b></blockquote></p><p> Biopharmaceutical company Ocugen, which focuses mainly on gene therapies to cure blindness diseases, had its ticker trending multiple times since the beginning of October.</p><p><blockquote>生物制药公司Ocugen主要专注于治疗失明疾病的基因疗法，自10月初以来，其股票价格已多次上涨。</blockquote></p><p> The company has become a meme focus and nearly doubled in price in the past few trading days.</p><p><blockquote>该公司已成为人们关注的焦点，在过去几个交易日内股价几乎翻了一番。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3e281fc931d00e6aa06e33fd23394521\" tg-width=\"547\" tg-height=\"557\" width=\"100%\" height=\"auto\"><span>Figure 2: OCGN stock sentiment on WSB.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图2：OCGN股票对WSB的情绪。</span></p></blockquote></p><p> The most likely catalyst behind the price surge is the anticipated World Health Organization’s approval of COVID-19 vaccine Covaxin.</p><p><blockquote>价格飙升背后最有可能的催化剂是预期的世界卫生组织批准COVID-19疫苗科瓦克辛。</blockquote></p><p> Ocugen is a co-development partner with Bharat Biotech on the drug, and it holds the rights to commercialize Covaxin in North America. Recent stage 3 results showed the drug to be efficient even against the delta variant, which could help in the approval process in these countries.</p><p><blockquote>Ocugen是该药物与Bharat Biotech的共同开发合作伙伴，并拥有科瓦克辛在北美的商业化权利。最近的第三阶段结果显示，该药物甚至对德尔塔变异毒株病毒也有效，这可能有助于这些国家的审批过程。</blockquote></p><p> Meanwhile, the stock is a bear target. OCGN has 56 million shares shorted, representing a whopping 29% of the float. While heavy shorting signals skepticism and caution, it can also put shares on the edge of a short squeeze — if or once massive buying volume takes place.</p><p><blockquote>与此同时，该股是看跌目标。OCGN有5600万股被做空，占流通股的29%。虽然大量做空表明怀疑和谨慎，但如果或一旦出现大量买盘，它也可能使股票处于轧空的边缘。</blockquote></p><p> The eventual vaccine approval could be the catalyst that sparks bullish short-term activity. The binary nature of this trade, however, offers much complexity and risk to both longs and shorts.</p><p><blockquote>最终的疫苗批准可能是引发看涨短期活动的催化剂。然而，这种交易的二元性质给多头和空头都带来了很大的复杂性和风险。</blockquote></p><p> <b>2. Progenity</b></p><p><blockquote><b>2.生殖</b></blockquote></p><p> Progenity (<b>PROG</b>) is a biotechnology company that develops molecular testing products in the US. With a market cap of $284 million, the company went public last year at $14 per share. Since then, share price has plummeted to below $1, giving PROG the infamous label of “penny stock”.</p><p><blockquote>后代（<b>程序</b>）是一家在美国开发分子检测产品的生物技术公司。该公司去年以每股14美元的价格上市，市值为2.84亿美元。此后，股价暴跌至1美元以下，给PROG贴上了臭名昭著的“细价股”标签。</blockquote></p><p> In the past month, PROG has spiked around 130%. As short interest on the stock climbed, the volume of comments on major web forums increased as well. Currently, according to Yahoo Finance’s latest data, nearly 24% of the float its being shorted.</p><p><blockquote>过去一个月，PROG飙升了130%左右。随着对该股的空头兴趣攀升，主要网络论坛上的评论量也有所增加。目前，根据雅虎财经的最新数据，其近24%的流通量被做空。</blockquote></p><p> Based on the company’s fundamentals, H.C. Wainwright’s Joseph Pantginis recently issued a report on PROG. The analyst started his coverage with a buy rating and 27% upside potential. His bull case is based on the company’s differentiated portfolio and the opportunities that it offers.</p><p><blockquote>基于公司的基本面，H.C.Wainwright的Joseph Pantginis最近发布了一份关于PROG的报告。该分析师以买入评级和27%的上涨潜力开始了他的报道。他的牛市理由是基于该公司差异化的投资组合及其提供的机会。</blockquote></p><p> <i>\"Progenity</i>’ <i>s differentiated R&D pipeline primarily focuses on employing proprietary ingestible device technologies, in tandem with delivery of de-risked</i> <i>FDA</i> <i>approved therapies.”</i> PROG’s popularity remains high, backed by Reddit forum discussions. Short interest is still elevated, despite the rally last month. This setup could lead the stock to a short squeeze.</p><p><blockquote><i>后代</i>’<i>差异化的研发管道主要专注于采用专有的可摄入设备技术，同时提供低风险的</i> <i>FDA</i> <i>批准的疗法。”</i>在Reddit论坛讨论的支持下，PROG的受欢迎程度仍然很高。尽管上个月有所反弹，但空头兴趣仍然很高。这种设置可能会导致该股出现空头挤压。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/0998a8e99f6ddce996a329ba5c7a179c\" tg-width=\"1076\" tg-height=\"405\" width=\"100%\" height=\"auto\"><span>Figure 3: Trending stocks on Reddit on November 2.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图3：11月2日Reddit上的趋势股票。</span></p></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Meme Stocks With Short Squeeze Potential In November<blockquote>11月2只具有逼空潜力的Meme股票</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Meme Stocks With Short Squeeze Potential In November<blockquote>11月2只具有逼空潜力的Meme股票</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">TheStreet</strong><span class=\"h-time small\">2021-11-03 20:31</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Wall Street Memes lists two meme stocks that might be on the verge of a short squeeze. Will OCGN and PROG head to the moon in November?</p><p><blockquote>华尔街模因列出了两只可能处于轧空边缘的模因股票。OCGN和PROG会在11月前往月球吗？</blockquote></p><p> “Meme frenzy” may seem to be hibernating, but it is certainly still alive under the sheets. Retail investors continue to monitor and debate several key stocks on the main discussion boards across the web, and some have started to move in the past few days – think GameStop on November 1, for example.</p><p><blockquote>“迷因狂潮”可能看起来正在冬眠，但它肯定仍然在床单下活着。散户投资者继续在网络上的主要讨论板上监控和辩论几只关键股票，其中一些股票在过去几天已经开始波动——例如，想想11月1日的游戏驿站。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/c8a435559be38d10b7251aa72e23a665\" tg-width=\"1240\" tg-height=\"698\" width=\"100%\" height=\"auto\"><span>Figure 1: Ocugen and Progenity logo.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图1：Ocugen和Progenity标志。</span></p></blockquote></p><p> Driven by popularity, momentum and elevated short interest, Wall Street Memes lists two meme stocks that have “mooning” potential in November.</p><p><blockquote>在受欢迎程度、势头和空头兴趣上升的推动下，华尔街模因列出了两只在11月份具有“月亮”潜力的模因股票。</blockquote></p><p> <b>1. Ocugen, Inc.</b></p><p><blockquote><b>1.Ocugen公司。</b></blockquote></p><p> Biopharmaceutical company Ocugen, which focuses mainly on gene therapies to cure blindness diseases, had its ticker trending multiple times since the beginning of October.</p><p><blockquote>生物制药公司Ocugen主要专注于治疗失明疾病的基因疗法，自10月初以来，其股票价格已多次上涨。</blockquote></p><p> The company has become a meme focus and nearly doubled in price in the past few trading days.</p><p><blockquote>该公司已成为人们关注的焦点，在过去几个交易日内股价几乎翻了一番。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3e281fc931d00e6aa06e33fd23394521\" tg-width=\"547\" tg-height=\"557\" width=\"100%\" height=\"auto\"><span>Figure 2: OCGN stock sentiment on WSB.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图2：OCGN股票对WSB的情绪。</span></p></blockquote></p><p> The most likely catalyst behind the price surge is the anticipated World Health Organization’s approval of COVID-19 vaccine Covaxin.</p><p><blockquote>价格飙升背后最有可能的催化剂是预期的世界卫生组织批准COVID-19疫苗科瓦克辛。</blockquote></p><p> Ocugen is a co-development partner with Bharat Biotech on the drug, and it holds the rights to commercialize Covaxin in North America. Recent stage 3 results showed the drug to be efficient even against the delta variant, which could help in the approval process in these countries.</p><p><blockquote>Ocugen是该药物与Bharat Biotech的共同开发合作伙伴，并拥有科瓦克辛在北美的商业化权利。最近的第三阶段结果显示，该药物甚至对德尔塔变异毒株病毒也有效，这可能有助于这些国家的审批过程。</blockquote></p><p> Meanwhile, the stock is a bear target. OCGN has 56 million shares shorted, representing a whopping 29% of the float. While heavy shorting signals skepticism and caution, it can also put shares on the edge of a short squeeze — if or once massive buying volume takes place.</p><p><blockquote>与此同时，该股是看跌目标。OCGN有5600万股被做空，占流通股的29%。虽然大量做空表明怀疑和谨慎，但如果或一旦出现大量买盘，它也可能使股票处于轧空的边缘。</blockquote></p><p> The eventual vaccine approval could be the catalyst that sparks bullish short-term activity. The binary nature of this trade, however, offers much complexity and risk to both longs and shorts.</p><p><blockquote>最终的疫苗批准可能是引发看涨短期活动的催化剂。然而，这种交易的二元性质给多头和空头都带来了很大的复杂性和风险。</blockquote></p><p> <b>2. Progenity</b></p><p><blockquote><b>2.生殖</b></blockquote></p><p> Progenity (<b>PROG</b>) is a biotechnology company that develops molecular testing products in the US. With a market cap of $284 million, the company went public last year at $14 per share. Since then, share price has plummeted to below $1, giving PROG the infamous label of “penny stock”.</p><p><blockquote>后代（<b>程序</b>）是一家在美国开发分子检测产品的生物技术公司。该公司去年以每股14美元的价格上市，市值为2.84亿美元。此后，股价暴跌至1美元以下，给PROG贴上了臭名昭著的“细价股”标签。</blockquote></p><p> In the past month, PROG has spiked around 130%. As short interest on the stock climbed, the volume of comments on major web forums increased as well. Currently, according to Yahoo Finance’s latest data, nearly 24% of the float its being shorted.</p><p><blockquote>过去一个月，PROG飙升了130%左右。随着对该股的空头兴趣攀升，主要网络论坛上的评论量也有所增加。目前，根据雅虎财经的最新数据，其近24%的流通量被做空。</blockquote></p><p> Based on the company’s fundamentals, H.C. Wainwright’s Joseph Pantginis recently issued a report on PROG. The analyst started his coverage with a buy rating and 27% upside potential. His bull case is based on the company’s differentiated portfolio and the opportunities that it offers.</p><p><blockquote>基于公司的基本面，H.C.Wainwright的Joseph Pantginis最近发布了一份关于PROG的报告。该分析师以买入评级和27%的上涨潜力开始了他的报道。他的牛市理由是基于该公司差异化的投资组合及其提供的机会。</blockquote></p><p> <i>\"Progenity</i>’ <i>s differentiated R&D pipeline primarily focuses on employing proprietary ingestible device technologies, in tandem with delivery of de-risked</i> <i>FDA</i> <i>approved therapies.”</i> PROG’s popularity remains high, backed by Reddit forum discussions. Short interest is still elevated, despite the rally last month. This setup could lead the stock to a short squeeze.</p><p><blockquote><i>后代</i>’<i>差异化的研发管道主要专注于采用专有的可摄入设备技术，同时提供低风险的</i> <i>FDA</i> <i>批准的疗法。”</i>在Reddit论坛讨论的支持下，PROG的受欢迎程度仍然很高。尽管上个月有所反弹，但空头兴趣仍然很高。这种设置可能会导致该股出现空头挤压。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/0998a8e99f6ddce996a329ba5c7a179c\" tg-width=\"1076\" tg-height=\"405\" width=\"100%\" height=\"auto\"><span>Figure 3: Trending stocks on Reddit on November 2.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图3：11月2日Reddit上的趋势股票。</span></p></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.thestreet.com/memestocks/other-memes/2-meme-stocks-with-short-squeeze-potential-in-november\">TheStreet</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"source_url":"https://www.thestreet.com/memestocks/other-memes/2-meme-stocks-with-short-squeeze-potential-in-november","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1194203181","content_text":"Wall Street Memes lists two meme stocks that might be on the verge of a short squeeze. Will OCGN and PROG head to the moon in November?\n“Meme frenzy” may seem to be hibernating, but it is certainly still alive under the sheets. Retail investors continue to monitor and debate several key stocks on the main discussion boards across the web, and some have started to move in the past few days – think GameStop on November 1, for example.\nFigure 1: Ocugen and Progenity logo.\nDriven by popularity, momentum and elevated short interest, Wall Street Memes lists two meme stocks that have “mooning” potential in November.\n1. Ocugen, Inc.\nBiopharmaceutical company Ocugen, which focuses mainly on gene therapies to cure blindness diseases, had its ticker trending multiple times since the beginning of October.\nThe company has become a meme focus and nearly doubled in price in the past few trading days.\nFigure 2: OCGN stock sentiment on WSB.\nThe most likely catalyst behind the price surge is the anticipated World Health Organization’s approval of COVID-19 vaccine Covaxin.\nOcugen is a co-development partner with Bharat Biotech on the drug, and it holds the rights to commercialize Covaxin in North America. Recent stage 3 results showed the drug to be efficient even against the delta variant, which could help in the approval process in these countries.\nMeanwhile, the stock is a bear target. OCGN has 56 million shares shorted, representing a whopping 29% of the float. While heavy shorting signals skepticism and caution, it can also put shares on the edge of a short squeeze — if or once massive buying volume takes place.\nThe eventual vaccine approval could be the catalyst that sparks bullish short-term activity. The binary nature of this trade, however, offers much complexity and risk to both longs and shorts.\n2. Progenity\nProgenity (PROG) is a biotechnology company that develops molecular testing products in the US. With a market cap of $284 million, the company went public last year at $14 per share. Since then, share price has plummeted to below $1, giving PROG the infamous label of “penny stock”.\nIn the past month, PROG has spiked around 130%. As short interest on the stock climbed, the volume of comments on major web forums increased as well. Currently, according to Yahoo Finance’s latest data, nearly 24% of the float its being shorted.\nBased on the company’s fundamentals, H.C. Wainwright’s Joseph Pantginis recently issued a report on PROG. The analyst started his coverage with a buy rating and 27% upside potential. His bull case is based on the company’s differentiated portfolio and the opportunities that it offers.\n\n\"Progenity’\n s differentiated R&D pipeline primarily focuses on employing proprietary ingestible device technologies, in tandem with delivery of de-risked \n FDA \n approved therapies.”\n\nPROG’s popularity remains high, backed by Reddit forum discussions. Short interest is still elevated, despite the rally last month. This setup could lead the stock to a short squeeze.\nFigure 3: Trending stocks on Reddit on November 2.","news_type":1,"symbols_score_info":{"PROG":0.9,"OCGN":0.9}},"isVote":1,"tweetType":1,"viewCount":2091,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":8,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/848084998"}
精彩评论